NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$22.95
+$0.37 (+1.64%)
Sep 22, 2026, 11:56 AM ET · Market open
Institutional Ownership
Net InflowTotal Institutions
182
Total Ownership
102.10%
Capital Flow
+$224.99M
Shares Change
+4.32M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: neutralEquity Sentiment & Activity
bullishNew Positions
25
Increased Positions
95
Reduced Positions
48
Closed Positions
41
New (25)
Increased (95)
Reduced (48)
Closed (41)
Options Sentiment & Activity
bearishPut/Call Ratio
1.843
Call Flow
292,800
Put Flow
539,500
Calls (35%)
Puts (65%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Viking Global Investors LP | 3.47% 0.00% | 0.27% | 4.2M | 94.92M | |
| Maverick Capital LTD | 2.70% +49.46% | 0.65% | 3.27M | 73.79M | |
| Point72 Asset Management LP | 0.14% 0.00% | < 0.01% | 168.9K | 3.81M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.p. | 13.99% -5.54% | 13.96% -12.59% | 16.94M 0.00% | 542.37M -8.75% | |
| Capital World Investors | 9.17% +5.11% | 0.05% +1.86% | 11.11M +11.27% | 355.6M +1.53% | |
| Ra Capital Management, L.p. | 7.89% -5.54% | 3.24% -5.63% | 9.55M 0.00% | 305.7M -8.75% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove NAMS